Millennium Pharmaceuticals, Inc. v. Baxter Healthcare Corporation
| Millennium Pharmaceuticals, Inc. |
| Baxter Healthcare Corporation |
| 1:2020cv00682 |
| May 20, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 28, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to August 10, 2020 - filed by Baxter Healthcare Corporation. (Rovner, Philip) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to August 10, 2020 filed by Baxter Healthcare Corporation. Set/Reset Answer Deadlines: Baxter Healthcare Corporation answer due 8/10/2020. Signed by Judge Colm F. Connolly on 5/28/2020. (fms)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 Return of Service Executed by Millennium Pharmaceuticals, Inc.. Baxter Healthcare Corporation served on 5/21/2020, answer due 6/11/2020. (Raucci, Anthony) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited for Millennium Pharmaceuticals, Inc. filed by Millennium Pharmaceuticals, Inc. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2 ;6,958,319 B2. (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 9, 2020. Date of Expiration of Patent: January 25, 2022.Thirty Month Stay Deadline: 7/25/2022* See attached(sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Baxter Healthcare Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2942437.) - filed by Millennium Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Millennium Pharmaceuticals, Inc. v. Baxter Healthcare Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Millennium Pharmaceuticals, Inc. | |
| Represented By: | Anthony David Raucci |
| Represented By: | Jack B. Blumenfeld |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Baxter Healthcare Corporation | |
| Represented By: | Philip A. Rovner |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
